Deep Track Biotechnology Master Fund Ltd has an estimated net worth of $1.31 Billion. This is based on reported shares across multiple companies, which include NEKTAR THERAPEUTICS, DYNAVAX TECHNOLOGIES CORP, and LB PHARMACEUTICALS INC.

2025 was Deep Track Biotechnology Master Fund Ltd's most active year for acquiring shares with 3 total transactions. Deep Track Biotechnology Master Fund Ltd's most active month to acquire stocks was the month of August. 2025 was Deep Track Biotechnology Master Fund Ltd's most active year for disposing of shares, totalling 3 transactions. Deep Track Biotechnology Master Fund Ltd's most active month to dispose stocks was the month of July. 2025 saw Deep Track Biotechnology Master Fund Ltd paying a total of $39,999,990.00 for 3,352,804 shares, this is the most they've acquired in one year. In 2025 Deep Track Biotechnology Master Fund Ltd cashed out on 18,731,804 shares for a total of $22,351,598.19, their largest year based on trade value.